Efficacy and safety of argatroban in patients with acute respiratory distress syndrome and extracorporeal lung support
Annals of Intensive Care Aug 09, 2017
Menk M, et al. – The goal of this investigation was to examine the feasibility, efficacy and safety of argatroban in critically ill acute respiratory distress syndrome (ARDS) patients undergoing extracorporeal lung support. Researchers reported that in these subjects, argatroban seemed to be a feasible, effective and safe anticoagulant.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries